Plato Investment Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.32K Buy
+12
New +$5.54K ﹤0.01% 469
2025
Q1
– Sell
-191
Closed -$63.7K – 578
2024
Q4
$63.7K Sell
191
-165
-46% -$56K ﹤0.01% 484
2024
Q3
$119K Sell
356
-4
-1% -$1.52K 0.01% 415
2024
Q2
$148K Buy
360
+165
+85% +$65.3K 0.01% 354
2024
Q1
$78.8K Buy
195
+52
+36% +$18.3K 0.01% 354
2023
Q4
$43.8K Buy
+143
New +$38.6K 0.05% 239

Other funds holding MEDP

Plato Investment Management's MEDP Position: Q2 2026 in Review

Plato Investment Management opened a new position in Medpace (MEDP) in Q2 2026: 12 shares worth $6.32K. The stake represents ﹤0.01% of the portfolio and ranks #469 among its holdings. This is a return to the name: Plato Investment Management previously reported a position in MEDP as recently as Q4 2024.

Plato Investment Management first reported a position in MEDP in Q4 2023 and has held it in 6 quarters since. The position peaked at $148K in Q2 2024. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Plato Investment Management held 12 shares of Medpace worth $6.32K as of Q2 2026.
  • Medpace was a new Plato Investment Management position in Q2 2026.
  • Medpace made up ﹤0.01% of Plato Investment Management's portfolio in Q2 2026, its #469 holding.
  • Plato Investment Management first reported a position in Medpace in Q4 2023 and has held it in 6 quarters since.
  • Plato Investment Management's Medpace position peaked at $148K in Q2 2024.
  • 700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Plato Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.